{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:43:48Z","timestamp":1777999428560,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["16103"],"award-info":[{"award-number":["16103"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007453","name":"Stiftung VERUM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-017-0309-z","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T06:58:14Z","timestamp":1507100294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["N-truncated A\u03b24\u2013x peptides in sporadic Alzheimer\u2019s disease cases and transgenic Alzheimer mouse models"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-0334","authenticated-orcid":false,"given":"Oliver","family":"Wirths","sequence":"first","affiliation":[]},{"given":"Susanne","family":"Walter","sequence":"additional","affiliation":[]},{"given":"Inga","family":"Kraus","sequence":"additional","affiliation":[]},{"given":"Hans W.","family":"Klafki","sequence":"additional","affiliation":[]},{"given":"Martina","family":"Stazi","sequence":"additional","affiliation":[]},{"given":"Timo J.","family":"Oberstein","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Ghiso","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[]},{"given":"Sascha","family":"Weggen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"309_CR1","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"309_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci. 1991;12:383\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"309_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204.","journal-title":"Annu Rev Neurosci"},{"key":"309_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1471-4159.2002.00985.x","volume":"82","author":"D Beher","year":"2002","unstructured":"Beher D, Wrigley JD, Owens AP, Shearman MS. Generation of C-terminally truncated amyloid-\u03b2 peptides is dependent on \u03b3-secretase activity. J Neurochem. 2002;82:563\u201375.","journal-title":"J Neurochem"},{"key":"309_CR5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-016-0294-7","volume":"4","author":"J Reinert","year":"2016","unstructured":"Reinert J, Richard BC, Klafki HW, Friedrich B, Bayer TA, Wiltfang J, Kovacs GG, Ingelsson M, Lannfelt L, Paetau A, et al. Deposition of C-terminally truncated A\u03b2 species A\u03b237 and A\u03b239 in Alzheimer\u2019s disease and transgenic mouse models. Acta Neuropathol Commun. 2016;4:24.","journal-title":"Acta Neuropathol Commun"},{"key":"309_CR6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J, et al. Potent amyloidogenicity and pathogenicity of A\u03b243. Nat Neurosci. 2011;14:1023\u201332.","journal-title":"Nat Neurosci"},{"key":"309_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-150394","volume":"49","author":"A Savastano","year":"2016","unstructured":"Savastano A, Klafki H, Haussmann U, Oberstein TJ, Muller P, Wirths O, Wiltfang J, Bayer TA. N-truncated A\u03b22\u2013X starting with position two in sporadic Alzheimer\u2019s disease cases and two Alzheimer mouse models. J Alzheimers Dis. 2016;49:101\u201310.","journal-title":"J Alzheimers Dis"},{"key":"309_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00702-009-0314-x","volume":"117","author":"O Wirths","year":"2010","unstructured":"Wirths O, Bethge T, Marcello A, Harmeier A, Jawhar S, Lucassen PJ, Multhaup G, Brody DL, Esparza T, Ingelsson M, et al. Pyroglutamate A\u03b2 pathology in APP\/PS1KI mice, sporadic and familial Alzheimer\u2019s disease cases. J Neural Transm. 2010;117:85\u201396.","journal-title":"J Neural Transm"},{"key":"309_CR9","first-page":"1823","volume":"149","author":"T Iwatsubo","year":"1996","unstructured":"Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Full-length amyloid-\u03b2(1\u201342(43)) and amino-terminally modified and truncated amyloid-\u03b242(43) deposit in diffuse plaques. Am J Pathol. 1996;149:1823\u201330.","journal-title":"Am J Pathol"},{"key":"309_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-9-13","volume":"9","author":"EA Guzman","year":"2014","unstructured":"Guzman EA, Bouter Y, Richard BC, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Wirths O, Bayer TA. Abundance of A\u03b25\u2013xlike immunoreactivity in transgenic 5XFAD, APP\/PS1KI and 3xTG mice, sporadic and familial Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:13.","journal-title":"Mol Neurodegener"},{"key":"309_CR11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.03-1070fje","volume":"18","author":"K Takeda","year":"2004","unstructured":"Takeda K, Araki W, Akiyama H, Tabira T. Amino-truncated amyloid \u03b2-peptide (A\u03b25-40\/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer\u2019s disease brain. FASEB J. 2004;18:1755\u20137.","journal-title":"FASEB J"},{"key":"309_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-006-0077-5","volume":"112","author":"K Liu","year":"2006","unstructured":"Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM. Characterization of A\u03b211-40\/42 peptide deposition in Alzheimer\u2019s disease and young Down\u2019s syndrome brains: implication of N-terminally truncated A\u03b2 species in the pathogenesis of Alzheimer\u2019s disease. Acta Neuropathol (Berl). 2006;112:163\u201374.","journal-title":"Acta Neuropathol (Berl)"},{"key":"309_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2011.09.071","volume":"505","author":"CP Sullivan","year":"2011","unstructured":"Sullivan CP, Berg EA, Elliott-Bryant R, Fishman JB, McKee AC, Morin PJ, Shia M, Fine RE. Pyroglutamate-A\u03b2 3 and 11 colocalize in amyloid plaques in Alzheimer\u2019s disease cerebral cortex with pyroglutamate-A\u03b2 11 forming the central core. Neurosci Lett. 2011;505:109\u201312.","journal-title":"Neurosci Lett"},{"key":"309_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K. Mass spectrometric characterization of brain amyloid \u03b2 isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2010;120:185\u201393.","journal-title":"Acta Neuropathol"},{"key":"309_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt121","volume":"4","author":"BD Moore","year":"2012","unstructured":"Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE. Overlapping profiles of A\u03b2 peptides in the Alzheimer\u2019s disease and pathological aging brains. Alzheimers Res Ther. 2012;4:18.","journal-title":"Alzheimers Res Ther"},{"key":"309_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","volume":"6","author":"MP Kummer","year":"2014","unstructured":"Kummer MP, Heneka MT. Truncated and modified amyloid-\u03b2 species. Alzheimers Res Ther. 2014;6:28.","journal-title":"Alzheimers Res Ther"},{"key":"309_CR17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","volume":"127","author":"TA Bayer","year":"2014","unstructured":"Bayer TA, Wirths O. Focusing the amyloid cascade hypothesis on N-truncated A\u03b2 peptides as drug targets against Alzheimer\u2019s disease. Acta Neuropathol. 2014;127:787\u2013801.","journal-title":"Acta Neuropathol"},{"key":"309_CR18","doi-asserted-by":"crossref","first-page":"23895","DOI":"10.1074\/jbc.270.41.23895","volume":"270","author":"CJ Pike","year":"1995","unstructured":"Pike CJ, Overman MJ, Cotman CW. Amino-terminal deletions enhance aggregation of \u03b2-amyloid peptides in vitro. J Biol Chem. 1995;270:23895\u20138.","journal-title":"J Biol Chem"},{"key":"309_CR19","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"309_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease. Arch Biochem Biophys. 1993;301:41\u201352.","journal-title":"Arch Biochem Biophys"},{"key":"309_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000369465","volume":"15","author":"E Portelius","year":"2015","unstructured":"Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H. Brain amyloid-\u03b2 fragment signatures in pathological ageing and Alzheimer\u2019s disease by hybrid immunoprecipitation mass spectrometry. Neurodegener Dis. 2015;15:50\u20137.","journal-title":"Neurodegener Dis"},{"key":"309_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2014.08.031","volume":"73","author":"TJ Oberstein","year":"2015","unstructured":"Oberstein TJ, Spitzer P, Klafki H-W, Linning P, Neff F, Kn\u00f6lker HJ, Lewczuk P, Wiltfang J, Kornhuber J, Maler JM. Astrocytes and microglia but not neurons preferentially generate N-terminally truncated A\u03b2 peptides. Neurobiol Dis. 2015;73:24\u201335.","journal-title":"Neurobiol Dis"},{"key":"309_CR23","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/ac401055y","volume":"85","author":"U Haussmann","year":"2013","unstructured":"Haussmann U, Jahn O, Linning P, Janssen C, Liepold T, Portelius E, Zetterberg H, Bauer C, Schuchhardt J, Knolker HJ, et al. Analysis of amino-terminal variants of amyloid-\u03b2 peptides by capillary isoelectric focusing immunoassay. Anal Chem. 2013;85:8142\u20139.","journal-title":"Anal Chem"},{"key":"309_CR24","doi-asserted-by":"crossref","first-page":"42645","DOI":"10.1074\/jbc.M102790200","volume":"276","author":"J Wiltfang","year":"2001","unstructured":"Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Ruther E, Kornhuber J, et al. Elevation of \u03b2-amyloid peptide 2-42 in sporadic and familial Alzheimer\u2019s disease and its generation in PS1 knockout cells. J Biol Chem. 2001;276:42645\u201357.","journal-title":"J Biol Chem"},{"key":"309_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-4159.2010.07118.x","volume":"116","author":"S Hahn","year":"2011","unstructured":"Hahn S, Bruning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer\u2019s disease attenuate the response of cultured cells to \u03b3-secretase modulators regardless of their potency and structure. J Neurochem. 2011;116:385\u201395.","journal-title":"J Neurochem"},{"key":"309_CR26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","volume":"165","author":"C Casas","year":"2004","unstructured":"Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, et al. Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated A\u03b2 42 accumulation in a novel Alzheimer transgenic model. Am J Pathol. 2004;165:1289\u2013300.","journal-title":"Am J Pathol"},{"key":"309_CR27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:196. e129\u201340.","journal-title":"Neurobiol Aging"},{"key":"309_CR28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-143120","volume":"45","author":"BC Richard","year":"2015","unstructured":"Richard BC, Kurdakova A, Baches S, Bayer TA, Weggen S, Wirths O. Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:1223\u201336.","journal-title":"J Alzheimers Dis"},{"key":"309_CR29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00001756-199805110-00043","volume":"9","author":"M Brockhaus","year":"1998","unstructured":"Brockhaus M, Grunberg J, Rohrig S, Loetscher H, Wittenburg N, Baumeister R, Jacobsen H, Haass C. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport. 1998;9:1481\u20136.","journal-title":"Neuroreport"},{"key":"309_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2051-5960-1-56","volume":"1","author":"G Antonios","year":"2013","unstructured":"Antonios G, Saiepour N, Bouter Y, Richard B, Paetau A, Verkkoniemi-Ahola A, Lannfelt L, Ingelsson M, Kovacs G, Pillot T, et al. N-truncated A\u03b2 starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathol Commun. 2013;1:56.","journal-title":"Acta Neuropathol Commun"},{"key":"309_CR31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","volume":"85","author":"N Sergeant","year":"2003","unstructured":"Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David JP, Vanmechelen E, Sergheraert C, Delacourte A. Truncated \u03b2-amyloid peptide species in pre-clinical Alzheimer\u2019s disease as new targets for the vaccination approach. J Neurochem. 2003;85:1581\u201391.","journal-title":"J Neurochem"},{"key":"309_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0304-3940(01)01876-6","volume":"306","author":"O Wirths","year":"2001","unstructured":"Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA. Intraneuronal A\u03b2 accumulation precedes plaque formation in \u03b2-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett. 2001;306:116\u201320.","journal-title":"Neurosci Lett"},{"key":"309_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","volume":"126","author":"Y Bouter","year":"2013","unstructured":"Bouter Y, Dietrich K, Wittnam JL, Rezaei-Ghaleh N, Pillot T, Papot-Couturier S, Lefebvre T, Sprenger F, Wirths O, Zweckstetter M, Bayer TA. N-truncated amyloid \u03b2 (A\u03b2) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Acta Neuropathol. 2013;126:189\u2013205.","journal-title":"Acta Neuropathol"},{"key":"309_CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.2006.00696.x","volume":"32","author":"H Lewis","year":"2006","unstructured":"Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, et al. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-\u03b2(42) peptide in vascular dementia. Neuropathol Appl Neurobiol. 2006;32:103\u201318.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"309_CR35","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.M007859200","volume":"276","author":"YM Kuo","year":"2001","unstructured":"Kuo YM, Kokjohn TA, Beach TG, Sue LI, Brune D, Lopez JC, Kalback WM, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Roher AE. Comparative analysis of amyloid-\u03b2 chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer\u2019s disease brains. J Biol Chem. 2001;276:12991\u20138.","journal-title":"J Biol Chem"},{"key":"309_CR36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/bi015685+","volume":"41","author":"W Kalback","year":"2002","unstructured":"Kalback W, Watson MD, Kokjohn TA, Kuo YM, Weiss N, Luehrs DC, Lopez J, Brune D, Sisodia SS, Staufenbiel M, et al. APP transgenic mice Tg2576 accumulate A\u03b2 peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer\u2019s disease senile plaques. Biochemistry. 2002;41:922\u20138.","journal-title":"Biochemistry"},{"key":"309_CR37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2009.05950.x","volume":"109","author":"J Sevalle","year":"2009","unstructured":"Sevalle J, Amoyel A, Robert P, Fournie-Zaluski MC, Roques B, Checler F. Aminopeptidase A contributes to the N-terminal truncation of amyloid \u03b2-peptide. J Neurochem. 2009;109:248\u201356.","journal-title":"J Neurochem"},{"key":"309_CR38","doi-asserted-by":"crossref","first-page":"33304","DOI":"10.1074\/jbc.M112.395608","volume":"287","author":"J Bien","year":"2012","unstructured":"Bien J, Jefferson T, \u010cau\u0161evi\u0107 M, Jumpertz T, Munter L, Multhaup G, Weggen S, Becker-Pauly C, Pietrzik CU. The metalloprotease meprin \u03b2 generates amino terminal-truncated amyloid \u03b2 peptide species. J Biol Chem. 2012;287:33304\u201313.","journal-title":"J Biol Chem"},{"issue":"5","key":"309_CR39","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1021\/acs.analchem.5b03891","volume":"88","author":"B Lyons","year":"2016","unstructured":"Lyons B, Friedrich MG, Raftery MJ, Truscott RJW. Amyloid plaque in the human brain can decompose from A\u03b21-40\/1-42 by spontaneous non-enzymatic processes. Anal Chem. 2016;88(5):2675\u201384.","journal-title":"Anal Chem"},{"key":"309_CR40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jalz.2016.03.011","volume":"12","author":"N Rudinskiy","year":"2016","unstructured":"Rudinskiy N, Fuerer C, Demurtas D, Zamorano S, De Piano C, Herrmann AG, Spires-Jones TL, Oeckl P, Otto M, Frosch MP, et al. Amyloid-\u03b2 oligomerization is associated with the generation of a typical peptide fragment fingerprint. Alzheimers Dement. 2016;12:996\u20131013.","journal-title":"Alzheimers Dement"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0309-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T03:19:51Z","timestamp":1570159191000},"score":1,"resource":{"primary":{"URL":"http:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0309-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s13195-017-0309-z","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"article-number":"80"}}